Physician profile

Lisa Klein

Dentist · Venice, FL

NPI 1639496003

$2,013.76

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$1,362.12
Food and Beverage$150.01
Education$100.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Kuraray America INC. $1,378.83 2023-2024
Biohorizons Implant Systems INC. $238.79 2019-2024 Biohorizons
Zimmer Biomet Holdings, INC. $165.43 2019
Straumann USA LLC $100.00 2023
Septodont INC. $72.93 2020
Orapharma, A Division of Bausch Health US, LLC $16.59 2021
Gc America INC. $14.67 2024 G-Aenial, Mi Paste, Equia
Ivoclar Vivadent, INC. $14.31 2024
Colgate Oral Pharmaceuticals, INC. $12.21 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Lisa Klein

$2,013.76

in general payments reported 2019-2025

Years
2019-2024
Top company
Kuraray America INC.

https://glasscript.com/doctor/210754/lisa-klein

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.